Novel Human Genetics Discoveries Using PacBio Long-Read Sequencing to be Presented at ASHG Annual Meeting

  • More than 38 presentations to feature SMRT® Sequencing, including data from the new Sequel™ System
  • New Sequel System chemistry to be released that dramatically reduces input DNA requirements

MENLO PARK, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology will be featured in more than 38 presentations at this week’s American Society of Human Genetics (ASHG) annual meeting taking place in Vancouver, Canada.

The company will also introduce a new Sequel System chemistry release (1.2.1) that enables loading of sequencing libraries with average insert size of 20-30 kb onto Sequel SMRT Cells with a ~50-fold reduction of DNA input requirement compared to previous Sequel chemistry. Internal results using the new Sequel System chemistry, which have been replicated at several beta sites, have shown mapped read-length N50s of >16 kb and output of >5 Gb per Sequel SMRT Cell. Additional details will be discussed during the company’s ASHG workshop (more details on the event below), and commercial availability is expected starting October 25, 2016.

Click on Arrow to Read More of This Release

Left Menu Icon
Right Menu Icon